title: Local administration of DFO-loaded lipid particles improves recovery after end-to-end reconstruction of rat median nerve.
abstract: OBJECTIVE
  The improvement of regeneration and functional recovery after peripheral nerve injury is a major challenge in neurosurgery. Although microsurgical techniques for nerve reconstruction have seen great advancements over the last years, the clinical outcome with patients is often unsatisfactory. The aim of the present study was to investigate if administration of the iron chelator Deferroxamine (DFO), can improve postoperative outcome in the rat median nerve reconstruction model.
  
  
  METHODS
  After complete transection, the right median nerve was repaired by end-to-end neurorrhaphy. The suture site was wrapped by a 1-cm-long external jugular vein segment, either empty or filled with DFO-loaded lipid particles (Perineurin or with a vehicle (unloaded lipid particles) alone. Functional testing was carried out weekly by means of the grasping test. At the time of withdrawal, 12 weeks post-operatively, muscle tropism recovery was assessed by weighing flexor digitorum sublimis muscle that is innervated by the median nerve only. Before harvesting of the nerve specimens electrophysiological analyses were performed with measuring the latency, the threshold and the conduction velocity. Finally, the repaired nerves were withdrawn for immunocytochemistry with a neurofilament antibody and axon quantitative morphology.
  
  
  RESULTS
  The comparison between the groups showed that intraoperative application of the DFO-loaded lipid particles at the neurorrhaphy site led to a significant increase in the density of regenerating axons as well as to an accelerated recovery of both muscle tropism and motor function. The electrophysiological results demonstrated a decrease of the threshold, a lower latency, and a higher conduction velocity in the Perineurin-treated animals.
  
  
  CONCLUSIONS
  The results of the present study suggest that local administration of Perineurin might have a therapeutic potential for improving the postoperative outcome after microsurgical nerve reconstruction in patients.
authors.affiliation: Klinik für Hand-, Plastische-, Rekonstruktive- und Verbrennungschirurgie, Universität Tübingen, BG-Unfallklinik, Germany. nsinis@bgu-tuebingen.de
authors.forename: Nektarios
authors.initials: N
authors.lastname: Sinis
authors.forename: Frederica
authors.initials: F
authors.lastname: Di Scipio
authors.forename: Phillip
authors.initials: P
authors.lastname: Schönle
authors.forename: Frank
authors.initials: F
authors.lastname: Werdin
authors.forename: Armin
authors.initials: A
authors.lastname: Kraus
authors.forename: Guido
authors.initials: G
authors.lastname: Koopmanns
authors.forename: Carmen
authors.initials: C
authors.lastname: Masanneck
authors.forename: Susanne
authors.initials: S
authors.lastname: Hermanns
authors.forename: Timm
authors.initials: T
authors.lastname: Danker
authors.forename: Elke
authors.initials: E
authors.lastname: Guenther
authors.forename: Max
authors.initials: M
authors.lastname: Haerle
authors.forename: Hans-Eberhard
authors.initials: HE
authors.lastname: Schaller
authors.forename: Stefano
authors.initials: S
authors.lastname: Geuna
authors.forename: Hans-Werner
authors.initials: HW
authors.lastname: Mueller
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003676:Deferoxamine / Q000008:administration & dosage / Q000494:pharmacology*; D004195:Disease Models, Animal; D004558:Electric Stimulation / Q000379:methods; D005260:Female; D008055:Lipids / Q000008:administration & dosage / Q000494:pharmacology; D020423:Median Neuropathy / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000503:physiopathology; D016900:Neurofilament Proteins / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D020127:Recovery of Function / Q000187:drug effects*; D017262:Siderophores / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D008055:Lipids; D016900:Neurofilament Proteins; D017262:Siderophores; C051774:neurofilament protein H; D003676:Deferoxamine